MENU
+Compare
CGEN
Stock ticker: NASDAQ
AS OF
Jul 18 closing price
Price
$1.54
Change
-$0.05 (-3.14%)
Capitalization
136.98M

CGEN Compugen Ltd Forecast, Technical & Fundamental Analysis

Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing its broadly applicable predictive computational discovery capabilities to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy... Show more

Industry: #Biotechnology
CGEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for CGEN with price predictions
Jul 18, 2025

Momentum Indicator for CGEN turns negative, indicating new downward trend

CGEN saw its Momentum Indicator move below the 0 level on July 11, 2025. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 93 similar instances where the indicator turned negative. In of the 93 cases, the stock moved further down in the following days. The odds of a decline are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for CGEN turned negative on July 07, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 50 similar instances when the indicator turned negative. In of the 50 cases the stock turned lower in the days that followed. This puts the odds of success at .

CGEN moved below its 50-day moving average on July 18, 2025 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CGEN declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for CGEN entered a downward trend on July 17, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 5 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CGEN advanced for three days, in of 236 cases, the price rose further within the following month. The odds of a continued upward trend are .

CGEN may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. CGEN’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.521) is normal, around the industry mean (18.109). P/E Ratio (60.333) is within average values for comparable stocks, (58.647). CGEN's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.460). Dividend Yield (0.000) settles around the average of (0.041) among similar stocks. P/S Ratio (5.035) is also within normal values, averaging (270.773).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CGEN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
CGEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

CGEN is expected to report earnings to fall 25.00% to -5 cents per share on July 31

Compugen Ltd CGEN Stock Earnings Reports
Q2'25
Est.
$-0.06
Q1'25
Missed
by $0.01
Q4'24
Missed
by $0.09
Q3'24
Beat
by $0.11
Q2'24
Beat
by $0.07
The last earnings report on May 19 showed earnings per share of -7 cents, missing the estimate of -7 cents. With 256.26K shares outstanding, the current market capitalization sits at 136.98M.
A.I. Advisor
published General Information

General Information

a maker of drug and diagnostics

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
26 Harokmim Street
Phone
+972 37658585
Employees
68
Web
https://www.cgen.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SVNLY5.930.01
+0.17%
Svenska Handelsbanken AB PUBL
WFHG7.41N/A
N/A
World Financial Holding Group
IHCPF10.23N/A
N/A
Inchcape PLC
OCGPF2.65N/A
N/A
Oceana Group Ltd.
PVCT0.07N/A
-0.22%
Provectus Biopharmaceuticals, Inc.

CGEN and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, CGEN has been loosely correlated with BDTX. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if CGEN jumps, then BDTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CGEN
1D Price
Change %
CGEN100%
-3.14%
BDTX - CGEN
47%
Loosely correlated
-2.49%
ROIV - CGEN
42%
Loosely correlated
-1.80%
ARWR - CGEN
41%
Loosely correlated
-11.09%
RLAY - CGEN
40%
Loosely correlated
-4.11%
BBIO - CGEN
39%
Loosely correlated
-0.49%
More